miRNA-140-5p: new avenue for pulmonary arterial hypertension drug development?

Rothman, A.M., Rowlands, D.J. and Lawrie, A. orcid.org/0000-0003-4192-9505 (2016) miRNA-140-5p: new avenue for pulmonary arterial hypertension drug development? Epigenomics. ISSN 1750-1911

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016 Future Medicine. This is an author produced version of a paper subsequently published in Epigenomics. Uploaded in accordance with the publisher's self-archiving policy
Keywords: SMURF1; miR140-5p; miRNA; pulmonary arterial hypertension; remodeling; ubiquitination
Dates:
  • Published: 7 September 2016
  • Published (online): 7 September 2016
  • Accepted: 8 August 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
BRITISH HEART FOUNDATIONFS/13/48/30453
MEDICAL RESEARCH COUNCILMR/K002406/1
Depositing User: Symplectic Sheffield
Date Deposited: 14 Sep 2016 09:58
Last Modified: 13 Sep 2017 10:28
Published Version: http://dx.doi.org/10.2217/epi-2016-0089
Status: Published
Publisher: Future Medicine
Refereed: Yes
Identification Number: https://doi.org/10.2217/epi-2016-0089
Related URLs:

Share / Export

Statistics